Matt Jacobson, Ph.D., is the Chair of the Department of Pharmaceutical Chemistry at UC San Francisco. He earned his Ph.D. in physical chemistry at MIT, and completed post-doctoral research at Oxford and Columbia. Matt’s research focuses on computational biophysics and computer-aided drug design; he is the author of over 120 publications. Software written by Matt and his collaborators is widely used in the pharmaceutical industry; he serves on the Scientific Advisory Board of Schrödinger, LLC, and is also a co-founder of Global Blood Therapeutics (NASDAQ: GBT), Relay Therapeutics and Cedilla Therapeutics. Matt received the NSF CAREER award, an Alfred P. Sloan Fellowship, and a School of Pharmacy teaching award. He has served on the editorial boards of several journals, including Biochemistry and PLoS Computational Biology.